Publications by authors named "Charise Gleason"

Claim this Profile
P
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Jonathan L Kaufman, Roberto Mina, Jatin J Shah, Jacob P Laubach, Ajay K Nooka, Charise Gleason

Clin Lymphoma Myeloma Leuk· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor.
Joseph Mikhael, Kimberly R Noonan, Beth Faiman, Charise Gleason, Ajay K Nooka

Clin Lymphoma Myeloma Leuk· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.
Ajay K Nooka, Nisha S Joseph, Jonathan L Kaufman, Leonard T Heffner, Vikas A Gupta, Charise Gleason

Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
Roberto Mina, Nisha S Joseph, Jonathan L Kaufman, Vikas A Gupta, Leonard T Heffner, Charise Gleason

Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study.
Jonathan L Kaufman, Roberto Mina, Andrzej J Jakubowiak, Todd L Zimmerman, Jeffrey J Wolf, Charise Gleason

Blood Cancer J· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab and its use in the treatment of relapsed and/or refractory multiple myeloma.
Sarah Chehab, Elyse Hall Panjic, Charise Gleason, Sagar Lonial, Ajay K Nooka

Future Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.
Randy A Taplitz, Erin B Kennedy, Eric J Bow, Jennie Crews, Charise Gleason

J Clin Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and Elotuzumab.
Ajay K Nooka, Charise Gleason, Marva Ollivierre Sargeant, Michelle Walker, Melanie Watson

J Oncol Pract· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
Randy A Taplitz, Erin B Kennedy, Eric J Bow, Jennie Crews, Charise Gleason

J Clin Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
.
Donna Catamero, Kimberly Noonan, Tiffany Richards, Beth Faiman, Cindy Manchulenko, Charise Gleason

Clin J Oncol Nurs· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Multiple Myeloma.
Charise Gleason, Donna D Catamero

Semin Oncol Nurs· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Treatment Strategies Making an Impact in Multiple Myeloma.
Charise Gleason, Jonathan Kaufman

J Adv Pract Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of health maintenance examinations and risk in myeloma patients.
Joseph D Tariman, Charise Gleason, Beth Faiman, Deborah Doss, Donna Catamero

Cancer Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down to the bitter end.
Sagar Lonial, Charise Gleason

Blood· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.
Ajay K Nooka, Jonathan L Kaufman, Madhusmita Behera, Amelia Langston, Edmund K Waller, Charise Gleason

Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.
Patricia A Mangan, Charise L Gleason, Teresa Miceli

Clin J Oncol Nurs· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Christopher R Flowers, Jerome Seidenfeld, Eric J Bow, Clare Karten, Charise Gleason

J Clin Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib.
Ajay Nooka, Charise Gleason, Daniela Casbourne, Sagar Lonial

Biologics· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
Jie Li, Ellie Hamilton, Louette Vaughn, Michael Graiser, Heather Renfroe, Charise Gleason

Transfusion· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine health maintenance in patients living with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
Elizabeth Bilotti, Charise L Gleason, Ann McNeill,

Clin J Oncol Nurs· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case report.
Mariam Rauf, Charise Gleason, Ajay K Nooka, Abbie Husman, Edmund K Waller

J Med Case Rep· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
Mojtaba Akhtari, Cynthia R Giver, Zahir Ali, Christopher R Flowers, Charise L Gleason

Transfusion· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving induction therapy in multiple myeloma.
Ajay Nooka, Charise Gleason, Sagar Lonial

Curr Hematol Malig Rep· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective study.
Jonathan L Kaufman, Ajay Nooka, Mark Vrana, Charise Gleason, L Thompson Heffner

Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of relapsed and refractory myeloma.
Jonathan Kaufman, Charise Gleason, Sagar Lonial

Curr Hematol Malig Rep· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis